Thyrotoxic hypokalemic paralysis: Discussion on 3 case reports;Die thyreotoxische hypokaliämische lähmung: Diskussion des krankheitsbildes anhand dreier fallberichte

Internist

Volumn 42, Issue 5, 2001, Pages 748-755

  Hahn, S ^a   Rudorff, K H ^b   Saller, B ^b   Mann, K ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; PATHOPHYSIOLOGY; RISK FACTOR; THYROTOXICOSIS;

ADULT; DIAGNOSIS, DIFFERENTIAL; ELECTROMYOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; HYPOKALEMIC PERIODIC PARALYSIS; MALE; MUSCLE WEAKNESS; MUSCLE, SKELETAL; POTASSIUM; RISK FACTORS; THYROID FUNCTION TESTS; TREATMENT OUTCOME;

EID: 0035007672     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050815     Document Type: Article

References (66)

1. 1. Ackermann MJ, Clapham DE (1997) Ion channel - Basic science and clinical disease. N Engl J Med 336: 1575-1586
2. 2. Aitken RCB, O'Connor PJ (1962) Muscular Weakness After Prolonged Ingestion of Thyroid. BMJ: 99-100
3. 3. Akhtér J, Weide LG (1997) Thyrotoxic periodic paralysis; a reversible cause of paralysis to remember. S D J Med 50: 357-358
4. 4. All K (1975) Hypokalaemic periodic paralysis complicating thyrotoxicosis. BMJ 4: 503-504
5. 5. Bernhard JD, Larson MA, Morris FH (1972) Thyrotoxic periodic paralysis of Mexican and Filipino ancestry. Calif Med 116: 70-74
6. 6. Berwaerts J, Verhelst J, Vandenbroucke M (1996) Thyrotoxic periodic paralysis, an unusual cause of hypokalemic periodic paralysis. Acta Neurol Belg 96: 301-306
7. 7. Biron R, Burger A, Chinet A, Clause T, Dubois-Ferriere R (1979) Thyroid hormones and the energetics of active sodium-potassium transport in mammalian skeletal muscles, J Physiol 297: 47-60
8. 8. Cattaneo FA (1998) Hypokalemic periodic paralysis: new advances, Schweiz Med Wochenschr 128; 297-301
9. 9. Celani MF, Bonati ME, Cavalli M (1995) Hypokalemic thyrotoxic periodic paralysis in a Caucasian male with Graves' disease. J Endocrinol Invest 18; 228-231
10. 10. Chan A, Shide R, Chow CC, Cockram CS, Swaminathan R (1991) In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ 303: 1096-1099
11. +-ATPase activity in thyrotoxic periodic paralysis. Clin Endocrinol 4: 213-216
12. 12. Conway MJ, Seibel JA, Eaton RP (1974) Thyrotoxicosis and periodic paralysis: Improvement with beta blockade. Ann Intern Med 81: 332-336
13. +-ATPase and bile flow by estrogen effects on liver surface membrane lipid structure and function. Proc Natl Acad Sci U S A 75: 4130-4134
14. 14. Dunlap HF, Kepler EJ (1931) A syndrome resembling familial periodic paralysis occuring in the course of exophthalmic goiter. Endocrinology 15: 541-546
15. 15. Dyken M, Zeman W, Rusche T (1969) Hypokalemic periodic paralysis. Children with permanent myopathic weakness. Neurology 19: 691-699
16. 16. Epstein FH, Rosa M (1983) Adrenergic control of serum potassium. N Engl J Med 309: 1450-1451
17. 17. Epstein FH, Ackermann MJ, Clapham DE (1997) Ion channels - basic science and clinical disease. N Engl J Med 336: 1575-1585
18. 18. Farid NR, Stone E, Johnson G (1980) Graves' disease and HLA: Clinical and epidemiologic associations. Clin Endocrinology 13: 535-544
19. 19. Feldmann DL, Goldberg WM (1969) Hyperthyroidism with periodic paralysis, Can Med Assoc J 101: 667-671
20. 20. Ferreiro J, Arguelles DJ, Rams H Jr (1986) Thyrotoxic periodic paralysis. Am J Med 80: 146-150
21. 21. Fisher J (1982) Thyrotoxic periodic paralysis with ventricular fibrillation. Arch Intern Med 142: 1362-1364
22. 22. Fontaine B, Vale-Santos J, Jurkat-Rott K et al. (1994) Mapping of the hypokalemic periodic paralysis locus to chromosome 1q31-32 in three european families. Nat Genet 6: 267-272
23. +-ATPase pump function in rat brain synaptosomes is different in males and females. Am J Physiol 142: E284-E289
24. 24. Ganong WF (1979) Lehrbuch der Medizinischen Physiologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokio
25. 25. Griggs RC, Engel WK, Resnick JS (1970) Acetazolamide treatment of hypokalemic paralysis. Prevention of attacks and improvement of persistant weakness. Ann Intern Med 73: 39-48
26. +-ATPase activity in male rats. Neurosci Lett 78: 97-100
27. 27. Guthrie GP, Curtis JJ, Beilmann KM (1978) Hypophosphatemia in thyrotoxic periodic paralysis. Arch Intern Med 138: 1284-1285
28. 28. Hawkins BR, Ma JTC, Lam KSL, Wang CCL, Yeung RTT (1985) Association of HLA antigens with thyrotoxic grave's disease and periodic paralysis in Hongkong Chinese. Clin Endocrinol 23: 245-252
29. 29. Hay ID, Mc Dougall IR (1975) Thyrotoxic periodic paralysis in Britain. BMJ: 761
30. 30. Hochberg DA, Vassolo M, Paniagua D (1996) Thyrotoxic periodic paralysis in a black man. South Med J 89: 735-737
31. 31. Hofmann WW, Smith RA (1970) Hypokalaemic periodic paralysis studied in vitro. Brain 93: 445-474
32. 32. Jackman RL, Jones RE (1964) Hyperthyroidism and periodic paralysis. Arch Intern Med 113: 657-664
33. 33. Kawa A, Nakamura S, Nakazawa M, Sakaguchi S, Kawabata T, Maeda Y, Kanehisa T (1977) HLA-BW35 and B 5 in Japanese patients with Graves' disease. Acta Endocrinol 86: 754-757
34. 34. Kelley DE, Gharib H, Kennedy FP, Duda RJ, Mc Manis PG (1989) Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch Intern Med 149: 2597-2600
35. 35. Kempf R, Wegmann D (1993) Periodische hypokaliämische Lähmung bei Thyreotoxikose. Schweiz Med Wochenschr 123: 1843-1845
36. 36. Kjeldsen K, Norgaard A, Gotzsche CO, Thomassen A, Clausen T (1984) Effect of thyroid function on number of Na-K pumps in human skeletal muscle. Lancet 11: 8-10
37. 37. Ko GT, Chow CC, Yeung VT (1996) Thyrotoxic periodic paralysis in a Chinese population. QJM 89: 463-468
38. 38. Kusakabe T, Yoshida M, Nishikawa M (1976) Thyrotoxic periodic paralysis: a peculiar case with unusual dystonic behavior and variable relations of paralysis to serum potassium levels. J Clin Endocrinol Metab 43: 730-738
39. 39. Layzer RB, Goldfield E (1974) Periodic paralysis caused by abuse of thyroid hormone. Neurology 24: 949-952
40. 40. Lazarus JH (1997) Hyperthyroidism. Lancet 349: 339-343
41. 41. Lee KO, Jaylor EA, Oh VMS, Cheah JS, Aw SE (1991) Hyperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis. Lancet 337: 1063-1064
42. 42. Manouklan MA, Foote JA, Crapo LM (1999) Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med 159; 601-606
43. 43. Mc Fadzean AJS, Yeung R (1967) Periodic paralysis complicating thyrotoxicosis in Chinese. BMJ 1: 451-455
44. 44. Mc Fadzean AJS, Yeung R (1969) Familial occurence of thyrotoxic periodic paralysis. BMJ 3: 760
45. 45. Nakao Y, Kishihara M, Baba Y, Kuma K, Fukunishi T, Imura H (1978) HLA antigens in autoimmune thyroid diseases. Arch Intern Med 138: 567-570
46. 46. Norris KC, Levine B, Genesan K (1996) Thyrotoxic periodic paralysis associated with hypokalemia and hypophosphatemia. Am J Kidney Dis 28: 270-273
47. 47. Ober KP, Hennessy JF (1981) Jodbasedow and thyrotoxic periodic paralysis. Arch Intern Med 14: 1225-1227
48. 48. Ober KP (1992) Thyrotoxic periodic paralysis in the united states. Report of 7 cases and review of the literarure. Medicine 71: 109-120
49. 49. Okihiro MM, Beddow RM (1965) Thyrotoxic periodic paralysis in Hawaii. Neurology 15: 253-255
50. 50. Okinaka S, Shizume K, Iino S et al. (1957) The association of periodic paralysis and hyperthyreoidism in Japan. J Clin Endocrinol 17: 1454-1459
51. 51. Piraino Neuenschwander P, Pumarino Carte H, Bidegain-Gonzalez F, Zura-Jimenez ML, Ferreiro-Merino F (1995) Thyrotoxic hypokalemic periodic paralysis: 18 cases with different forms of thyreotoxicosis. Rev Clin Esp 195: 294-297
52. 52. Resnick JS, Engel WK, Griggs RC, Stam AC (1968) Acetazoiamide prophylaxis in hypokalemic periodic paralysis. N Engl J Med 278: 582-586
53. 53. Rosenfeld M (1902) Acute aufsteigende Lähmung bei Morbus Basedow. Berlin Klin Wochschr 23: 538-540
54. 54. Rüdel R, Lehmann-Horn F, Ricker K, Küther G (1984) Hypokalemic periodic paralysis. Muscle Nerve 7: 110-120
55. 55. Saeian K, Heckling PS (1988) Thyrotoxic periodic paralysis in a hispanic man. Arch Intern Med 148: 708
56. 56. Satoyoshi E, Murakami K, Kowa H, Kinoshita M, Nishiyama Y (1963) Periodic paralysis in hyperthyroidism. Neurology 13: 746-752
57. 57. Satoyoshi E, Murakami K, Kowa H et al. (1963) Myopathy in thyrotoxicosis. Neurology 13: 645-658
58. 58. Schmidt RF, Thews G Lang F (2000) Physiologie des Menschen, 28. Aufl. Springer, Berlin Heidelberg New York Tokio
59. 59. Schutta HS, Armitage JL (1969) Thyrotoxic hypokalemic periodic paralysis. J Neuropath Exp Neurol 28: 321-336
60. 60. Schulze-Bonhage A, Fiedler M, Ferbert A (1996) Episodische Lähmung als Erstmanifestation einer Hyperthyreose. Dtsch Med Wochenschr 121: 1498-1500
61. 61. Shayne P, Hart A (1994)Thyrotoxic periodic paralysis terminated with intravenous propanolol. Ann Emerg Med 24: 736-740
62. 62. Talbott JH (1941) Periodic paralysis: a clinical syndrome. Medidne 20: 85-143
63. 63. Tamai HJ, Tanaka K, Komaki G et al. (1987) HLA and thyrotoxic periodic paralysis in Japanese patients. J Clin Endocrinol Metabol 64: 1075-1078
64. 64. Uno H, Sasazuki T, Tamai H, Matsumoto H (1981) Two major genes, linked to HLA and Gm, control susceptility to Graves' disease. Nature 292: 768-770
65. 65. Yeo PPB, Chan SH, Lui KF, Wee GB, Lim P, Cheah JS (1978) HLA and thyrotoxic periodic paralysis. BMJ : 930
66. 66. Yeung RTT, Tse TF (1974) Thyrotoxic periodic paralysis. Effect of Propranolol. Am J Med 57: 584-590